NCT00416442View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

RSV604

Trial Locations (1)

Unknown

Novartis Investigative Site, Horsham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY